2022/12/29 ALA -1300 Received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI), NO: MX/a/2020/008471Post author:alarpharmPost published:1 . 2 . 2023Post category:Media releases You Might Also Like 2023/11/13 ALA-3000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 109100921) 29 . 2 . 2024 2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024 2020/08/03 ALA -1000 Receive notice of patent allowance from the IP Australia. 25 . 8 . 2020 2022/05/12 ALA-1000 Received notice of patent allowance from European Patent Office (EPO) , Application No. 17850245.6 13 . 5 . 2022 2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023
2023/11/13 ALA-3000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 109100921) 29 . 2 . 2024
2023/10/12 ALA-2000 has received a notice of allowance from Taiwan Intellectual Property Office (TIPO) after examination. (Patent Application No. 108147847) 29 . 2 . 2024
2022/05/12 ALA-1000 Received notice of patent allowance from European Patent Office (EPO) , Application No. 17850245.6 13 . 5 . 2022
2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023